Pictet-Biotech I dy GBP

Register to Unlock Ratings
Performance History31/03/2024
Growth of 1,000 (GBP) Advanced Graph
Pictet-Biotech I dy GBP
Fund24.9-6.7-4.58.94.8
+/-Cat-1.12.33.410.22.5
+/-B’mrk-8.0-7.0-6.91.6-3.7
 
Key Stats
NAV
22/04/2024
 GBP 813.28
Day Change 0.28%
Morningstar Category™ Sector Equity Biotechnology
IA (formerly IMA) Sector Specialist
ISIN LU0448836352
Fund Size (Mil)
22/04/2024
 USD 1371.96
Share Class Size (Mil)
22/04/2024
 GBP 18.90
Max Initial Charge 5.00%
Ongoing Charge
18/04/2024
  1.10%
Investment Objective: Pictet-Biotech I dy GBP
This Compartment applies a capital growth strategy by investing at least two-thirds of its total assets/total wealth in equities or similar securities issued by biopharmaceutical companies throughout the world (including emerging countries). However, in light of the particularly innovative nature of the pharmaceutical industry in North America and Western Europe, the vast majority of investments will be made in these regions. To capitalise on particularly innovative projects in the pharmaceuticals field, the Biotech Compartment may invest up to 10% of its net assets in Private Equity and/or unlisted securities.
Returns
Trailing Returns (GBP)22/04/2024
YTD-3.67
3 Years Annualised-0.45
5 Years Annualised6.40
10 Years Annualised8.34
12 Month Yield 0.00
Dividend Paying Frequency Annually
Management
Manager Name
Start Date
Tazio Storni
26/05/2016
Marco Minonne
01/06/2020
Click here to see others
Inception Date
10/09/2009
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
MSCI ACWI NR EURMorningstar Gbl Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Pictet-Biotech I dy GBP31/03/2024
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock98.900.0098.90
Bond0.040.10-0.06
Property0.000.000.00
Cash1.650.491.16
Other0.000.000.00
Top 5 Regions%
United States91.96
United Kingdom2.11
Eurozone2.06
Europe - ex Euro2.01
Canada1.85
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Moderna IncHealthcareHealthcare4.98
argenx SE ADRHealthcareHealthcare4.25
Viking Therapeutics IncHealthcareHealthcare3.94
Biomarin Pharmaceutical IncHealthcareHealthcare3.86
Blueprint Medicines CorpHealthcareHealthcare3.82
Pictet-Biotech I dy GBP

Related

* This share class has performance data calculated prior to the inception date, 2009-09-10. This is based upon a simulated/extended track record, using the track record of Pictet-Biotech P dy GBP (ISIN: LU0320646986), and is in accordance with Morningstar’s Extended Performance Methodology paper. To find out more about this, click here.
In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures